ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 133 filers reported holding ANIKA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.56 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $200,046 | +97961.8% | 7,700 | +11.6% | 0.00% | -33.3% |
| Q4 2022 | $204 | -99.9% | 6,900 | -1.4% | 0.01% | 0.0% |
| Q4 2021 | $251,000 | -15.8% | 7,000 | 0.0% | 0.01% | -14.3% |
| Q3 2021 | $298,000 | +6.0% | 7,000 | +7.7% | 0.01% | 0.0% |
| Q2 2021 | $281,000 | +6.0% | 6,500 | 0.0% | 0.01% | 0.0% |
| Q1 2021 | $265,000 | -9.9% | 6,500 | 0.0% | 0.01% | -22.2% |
| Q4 2020 | $294,000 | +25.6% | 6,500 | -1.5% | 0.01% | -18.2% |
| Q3 2020 | $234,000 | -8.6% | 6,600 | +33.9% | 0.01% | -15.4% |
| Q4 2019 | $256,000 | -8.6% | 4,930 | -3.3% | 0.01% | -13.3% |
| Q3 2019 | $280,000 | +32.1% | 5,100 | -3.8% | 0.02% | +36.4% |
| Q2 2019 | $212,000 | -21.5% | 5,300 | -17.2% | 0.01% | -8.3% |
| Q3 2018 | $270,000 | +28.0% | 6,400 | -3.0% | 0.01% | +20.0% |
| Q2 2018 | $211,000 | -34.7% | 6,600 | +1.5% | 0.01% | -33.3% |
| Q1 2018 | $323,000 | -5.0% | 6,500 | +3.2% | 0.02% | 0.0% |
| Q4 2017 | $340,000 | -0.6% | 6,300 | +6.8% | 0.02% | -6.2% |
| Q3 2017 | $342,000 | +15.5% | 5,900 | -1.7% | 0.02% | +6.7% |
| Q2 2017 | $296,000 | +13.4% | 6,000 | 0.0% | 0.02% | +15.4% |
| Q1 2017 | $261,000 | -9.7% | 6,000 | +1.7% | 0.01% | -13.3% |
| Q4 2016 | $289,000 | -7.1% | 5,900 | -9.2% | 0.02% | -6.2% |
| Q3 2016 | $311,000 | -8.0% | 6,500 | +3.2% | 0.02% | -11.1% |
| Q2 2016 | $338,000 | +19.9% | 6,300 | 0.0% | 0.02% | +20.0% |
| Q1 2016 | $282,000 | +13.7% | 6,300 | -3.1% | 0.02% | +15.4% |
| Q4 2015 | $248,000 | +21.6% | 6,500 | +1.6% | 0.01% | +18.2% |
| Q3 2015 | $204,000 | -5.1% | 6,400 | -1.5% | 0.01% | +10.0% |
| Q2 2015 | $215,000 | -19.8% | 6,500 | 0.0% | 0.01% | -23.1% |
| Q1 2015 | $268,000 | -0.4% | 6,500 | -1.5% | 0.01% | +8.3% |
| Q4 2014 | $269,000 | +9.3% | 6,600 | -1.5% | 0.01% | 0.0% |
| Q3 2014 | $246,000 | -3.5% | 6,700 | +21.8% | 0.01% | 0.0% |
| Q2 2014 | $255,000 | +19.2% | 5,500 | +5.8% | 0.01% | +20.0% |
| Q1 2014 | $214,000 | – | 5,200 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Technologies Management, LLC | 44,875 | $2,031,000 | 2.14% |
| Parian Global Management LP | 102,705 | $4,648,000 | 1.16% |
| CAPITAL MANAGEMENT CORP /VA | 93,035 | $4,211,000 | 1.15% |
| Avidity Partners Management LP | 731,000 | $33,085,000 | 1.07% |
| Sio Capital Management, LLC | 65,382 | $2,959,000 | 0.61% |
| DIKER MANAGEMENT LLC | 21,835 | $988,000 | 0.50% |
| Archon Capital Management LLC | 48,925 | $2,214,000 | 0.38% |
| Caption Management, LLC | 362,800 | $16,420,000 | 0.37% |
| KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | 1,546,260 | $69,984,000 | 0.20% |
| Boston Trust Walden Corp | 378,167 | $17,116,000 | 0.18% |